Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: An RTOG analysis

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages 983-989

  Machtay, Mitchell ^a   Moughan, Jennifer ^b   Farach, Andrew ^c,d   Martin O'Meara, Elizabeth ^b   Galvin, James ^b,c   Garden, Adam S ^e   Weber, Randal S ^f   Cooper, Jay S ^g   Forastiere, Arlene ^a   Ang, K Kian ^e  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f MAIMONIDES MEDICAL CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCURRENCY CONTROL; DOSIMETRY; MULTIVARIANT ANALYSIS; RADIOTHERAPY; REGRESSION ANALYSIS;

CONCURRENT CHEMORADIATION; LOCALLY ADVANCED HEAD AND NECK CANCERS; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSIONS; RADIATION THERAPY ONCOLOGY GROUPS; SIGNIFICANT VARIABLES; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS;

TOXICITY;

CISPLATIN; FLUOROURACIL; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; ASPIRATION PNEUMONIA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CASE CONTROL STUDY; CHEMORADIOTHERAPY; CLINICAL FEATURE; CONTROLLED STUDY; DOSIMETRY; DRUG MEGADOSE; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX; LARYNX DISORDER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; ORGANS AT RISK; OROPHARYNX; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PHARYNGITIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RESPIRATORY TRACT FISTULA; RETROSPECTIVE STUDY; SECONDARY ANALYSIS; TREATMENT DURATION; TREATMENT PLANNING; AGE; AGED; HEAD AND NECK TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; SURVIVOR;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNX; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANS AT RISK; PATIENT SELECTION; RADIATION INJURIES; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVORS;

EID: 84872066751     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.03.005     Document Type: Article

References (24)

1. Pignon JP, LeMaitre A, Maillard E, et al. Meta-analysis in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92(1): 4-14.
2. Brizel DM, Albers MA, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 328: 1798-1804.
3. Wendt TG, Grabenbauer CG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998; 16: 1318-1324.
4. Olmi P, Crispino S, Fallai C, et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy-a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003; 55: 78-92.
5. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: results of a multicentric randomized German trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2001; 50: 1161-1171.
6. Bensadoun RJ, Benezery K, Dassonville O, et al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys 2006; 64: 983-994.
7. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66: 253-262.
8. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2003; 22: 69-76.
9. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 53(1): 23-28.
10. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
11. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004; 60: 1425-1439.
12. Dirix P, Abbeel S, Vanstraelen B, et al. Dysphagia after chemo-radiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2009; 75(2): 385-392.
13. Caudell JJ, Schaner PE, Desmond RA, et al. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010; 76(2): 403-409.
14. Teguh D, Levendag P, Sewnaik A, et al. Results of fiberoptic endo-scopic evaluation of swallowing vs radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx. Radiother Oncol 2008; 89(1): 57-63.
15. Lavendag P, Teguh D, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007; 85(1): 64-73.
16. Feng FY, Kim HM, Lyden TH, et al. Intensity modulated chemo-radiotherapy aiming to reduce dysphagia in patienst with oropharyn-geal cancer: clinical and functional results. J Clin Oncol 2010; 28(16): 2732-2738.
17. Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78(5): 1356-1365.
18. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
19. Garden AS, Harris J, Vokes E, et al. Preliminary results of RTOG 9703: a phase II randomized trial of concurrent radiation (RT) and chemotherapy for advanced squamous cell carcinomas (SCC) of the head. J Clin Oncol 2004; 22(14): 2856-2864.
20. Ang KK, Harris J, Garden A, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol 2005; 23: 3008-3015.
21. Cox J, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31(5): 1341-1346.
22. Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007 Oct; 85(1): 74-82.
23. Feng F, Kim H, Lyden T, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68(5): 1289-1298.
24. Caglar HB, Tishler RB, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008 Nov 15; 72(4): 1110-1118.